![Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1d41ebf5-9657-435f-9dff-165db3d18406/gr2_lrg.jpg)
Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet
![PDF) CHAMPION∗ Trial Rationale and Design: The Long-Term Safety and Clinical Efficacy of a Wireless Pulmonary Artery Pressure Monitoring System | Lynne Stevenson - Academia.edu PDF) CHAMPION∗ Trial Rationale and Design: The Long-Term Safety and Clinical Efficacy of a Wireless Pulmonary Artery Pressure Monitoring System | Lynne Stevenson - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/40153199/mini_magick20190221-6661-r3owg9.png?1550805902)
PDF) CHAMPION∗ Trial Rationale and Design: The Long-Term Safety and Clinical Efficacy of a Wireless Pulmonary Artery Pressure Monitoring System | Lynne Stevenson - Academia.edu
![Pro Position: The Data - Phoenix and Meta-Analysis of the Champion Clinical Trial Program! | tctmd.com Pro Position: The Data - Phoenix and Meta-Analysis of the Champion Clinical Trial Program! | tctmd.com](https://s3.amazonaws.com/prod.tctmd.com/public/2013-10/122674.png)
Pro Position: The Data - Phoenix and Meta-Analysis of the Champion Clinical Trial Program! | tctmd.com
![Pulmonary artery pressure‐guided heart failure management: US cost‐effectiveness analyses using the results of the CHAMPION clinical trial - Martinson - 2017 - European Journal of Heart Failure - Wiley Online Library Pulmonary artery pressure‐guided heart failure management: US cost‐effectiveness analyses using the results of the CHAMPION clinical trial - Martinson - 2017 - European Journal of Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/8f5b43ba-72a5-4d05-b45d-6110acfdba30/ejhf642-fig-0003-m.jpg)
Pulmonary artery pressure‐guided heart failure management: US cost‐effectiveness analyses using the results of the CHAMPION clinical trial - Martinson - 2017 - European Journal of Heart Failure - Wiley Online Library
![Cangrelor: Pharmacology, Clinical Data, and Role in Percutaneous Coronary Intervention. | Semantic Scholar Cangrelor: Pharmacology, Clinical Data, and Role in Percutaneous Coronary Intervention. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/eabc6d1d8583c3b23fd3388bf84ce3a6bb286c23/6-Table1-1.png)
Cangrelor: Pharmacology, Clinical Data, and Role in Percutaneous Coronary Intervention. | Semantic Scholar
![CIENCIASMEDICASNEWS: MSD and Ferring Pharmaceuticals Complete Largest Ever Clinical Trial in Postpartum Haemorrhage CIENCIASMEDICASNEWS: MSD and Ferring Pharmaceuticals Complete Largest Ever Clinical Trial in Postpartum Haemorrhage](https://www.news-medical.net/image.axd?picture=2018%2F2%2Fferring_info.jpg)
CIENCIASMEDICASNEWS: MSD and Ferring Pharmaceuticals Complete Largest Ever Clinical Trial in Postpartum Haemorrhage
![PDF) Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: Comparison of adverse event–free response days in the CHAMPION trial | Andrew Yu - Academia.edu PDF) Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: Comparison of adverse event–free response days in the CHAMPION trial | Andrew Yu - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/41968545/mini_magick20190218-3685-11au8mj.png?1550507435)
PDF) Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: Comparison of adverse event–free response days in the CHAMPION trial | Andrew Yu - Academia.edu
![MCC Announces: Clinical Trial Risk and Performance Management Summit, Nov. 14-15, 2018, Princeton, NJ MCC Announces: Clinical Trial Risk and Performance Management Summit, Nov. 14-15, 2018, Princeton, NJ](http://ww1.prweb.com/prfiles/2018/09/28/15801921/11-14-18-CT%20Risk%20and%20Performance%20Mngmnt%20Summit-960x219-Banner.png)
MCC Announces: Clinical Trial Risk and Performance Management Summit, Nov. 14-15, 2018, Princeton, NJ
![Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial - The Lancet Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/247a7cdc-1ace-452a-8253-84895f686c62/gr1.jpg)
Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial - The Lancet
![CLINICAL TRIALS - Spotlight on Quality in Study Startup: Automated Workflows Encourage Upfront Planning & Downstream Improvements in the eTMF CLINICAL TRIALS - Spotlight on Quality in Study Startup: Automated Workflows Encourage Upfront Planning & Downstream Improvements in the eTMF](https://d2akihtr51eb46.cloudfront.net/wp-content/uploads/2019/01/T1-1.jpg)
CLINICAL TRIALS - Spotlight on Quality in Study Startup: Automated Workflows Encourage Upfront Planning & Downstream Improvements in the eTMF
![CLINICAL TRIALS - Spotlight on Quality in Study Startup: Automated Workflows Encourage Upfront Planning & Downstream Improvements in the eTMF CLINICAL TRIALS - Spotlight on Quality in Study Startup: Automated Workflows Encourage Upfront Planning & Downstream Improvements in the eTMF](https://d2akihtr51eb46.cloudfront.net/wp-content/uploads/2019/01/F1-5.jpg)